Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

Name: Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial
SKU: 2744
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 2 Articles Tags: aripiprazole, atypical-antipsychotics, bs, ccrc, gerardo-villarreal, gregory-toney, jacob-pickard, jose-m-cañive-md, lawrence-a-calais, ma, md, pharmd, ptsd, rn, s-laura-lundy

Description

Description

Jose M. Cañive MD Link

ORIGINAL RESEARCH

Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Post Traumatic Stress Disorder: An Open Trial

Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

Description

Jose M. Cañive MD Link

ORIGINAL RESEARCH

Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Post Traumatic Stress Disorder: An Open Trial

Gerardo Villarreal, MD, Lawrence A. Calais, RN, CCRC, Jose M. Cañive MD, S. Laura Lundy, BS, Jacob Pickard, MA, and Gregory Toney, PharmD

Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial

Psychopharmacology Bulletin VOL 49 No. 1, 2019 – Full Issue Stacked PDF

Terence A. Ketter, MD: Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder

Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening

Jose M. Cañive MD: Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Posttraumatic Stress Disorder: An Open Trial

Description

Jose M. Cañive MD Link

ORIGINAL RESEARCH

Prospective Study to Evaluate the Efficacy of Aripiprazole as a Monotherapy in Patients with Severe Chronic Post Traumatic Stress Disorder: An Open Trial

Gerardo Villarreal, MD, Lawrence A. Calais, RN, CCRC, Jose M. Cañive MD, S. Laura Lundy, BS, Jacob Pickard, MA, and Gregory Toney, PharmD

Related products

Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial

Psychopharmacology Bulletin VOL 49 No. 1, 2019 – Full Issue Stacked PDF

Terence A. Ketter, MD: Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder

Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening